Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$0.42 - $0.72 $3,648 - $6,254
8,687 Added 30.21%
37,442 $23,000
Q3 2023

Nov 06, 2023

BUY
$0.6 - $1.53 $1,399 - $3,569
2,333 Added 8.83%
28,755 $17,000
Q2 2023

Jul 27, 2023

SELL
$1.05 - $1.63 $647 - $1,005
-617 Reduced 2.28%
26,422 $29,000
Q1 2023

May 02, 2023

BUY
$1.2 - $2.73 $1,046 - $2,380
872 Added 3.33%
27,039 $36,000
Q4 2022

Feb 09, 2023

SELL
$1.71 - $3.61 $97,675 - $206,203
-57,120 Reduced 68.58%
26,167 $48,000
Q3 2022

Nov 02, 2022

BUY
$1.9 - $8.63 $108,672 - $493,601
57,196 Added 219.22%
83,287 $205,000
Q2 2022

Aug 01, 2022

SELL
$2.13 - $9.01 $9,834 - $41,599
-4,617 Reduced 15.04%
26,091 $64,000
Q1 2022

May 04, 2022

BUY
$6.28 - $15.59 $23,267 - $57,760
3,705 Added 13.72%
30,708 $163,000
Q4 2021

Feb 07, 2022

SELL
$14.7 - $28.67 $5,600 - $10,923
-381 Reduced 1.39%
27,003 $412,000
Q3 2021

Nov 02, 2021

SELL
$24.31 - $33.6 $774,443 - $1.07 Million
-31,857 Reduced 53.78%
27,384 $779,000
Q2 2021

Aug 03, 2021

SELL
$26.09 - $40.4 $178,768 - $276,820
-6,852 Reduced 10.37%
59,241 $2 Million
Q1 2021

May 04, 2021

SELL
$33.06 - $56.93 $34.3 Million - $59.1 Million
-1,038,431 Reduced 94.02%
66,093 $2.53 Million
Q4 2020

Feb 01, 2021

SELL
$39.09 - $57.4 $23.7 Million - $34.8 Million
-605,709 Reduced 35.42%
1,104,524 $46.2 Million
Q3 2020

Nov 09, 2020

BUY
$28.43 - $44.67 $17.6 Million - $27.7 Million
620,142 Added 56.89%
1,710,233 $74.1 Million
Q2 2020

Aug 07, 2020

BUY
$11.71 - $30.29 $9.39 Million - $24.3 Million
801,720 Added 278.02%
1,090,091 $33 Million
Q1 2020

May 04, 2020

SELL
$7.64 - $27.5 $15.2 Million - $54.8 Million
-1,992,398 Reduced 87.36%
288,371 $3.94 Million
Q4 2019

Feb 06, 2020

SELL
$15.02 - $20.57 $378,323 - $518,117
-25,188 Reduced 1.09%
2,280,769 $36.8 Million
Q4 2019

Feb 04, 2020

BUY
$15.02 - $20.57 $11.1 Million - $15.1 Million
736,287 Added 46.91%
2,305,957 $43 Million
Q3 2019

Nov 12, 2019

SELL
$18.85 - $27.5 $6.77 Million - $9.87 Million
-358,985 Reduced 18.61%
1,569,670 $30.2 Million
Q2 2019

Aug 15, 2019

BUY
$17.37 - $26.27 $12.7 Million - $19.2 Million
731,720 Added 61.13%
1,928,655 $45.3 Million
Q1 2019

May 03, 2019

BUY
$10.65 - $25.75 $11.6 Million - $28.1 Million
1,091,260 Added 1032.66%
1,196,935 $28 Million
Q1 2018

May 04, 2018

BUY
$4.69 - $10.05 $495,615 - $1.06 Million
105,675 New
105,675 $496,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.